SUMO-Specific Peptidase 5 Promotes Oesophageal Squamous Cell Carcinoma Growth through the NF-κB-SLC1A3 Axis
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl27047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Chaoxiang Du und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, 200032 Shanghai, China. Hauptthemen laut MEDLINE: Esophageal Neoplasms, NF-kappa B, Esophageal Squamous Cell Carcinoma, Cysteine Endopeptidases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Training Team for the Leading Expert Team of "Famous Doctors in Jiyang" in Jiangyin City - Tan Lijie Expert Team, Research project of the Jiangyin Health Commission, 2021 Clinical Research Navigation Program of Shanghai Medical College of Fudan University.
Abstract (Originalsprache)
Background
This study investigates the role of small ubiquitin-like modifier (SUMO)-specific peptidase 5 (SENP5), a key regulator of SUMOylation, in esophageal squamous cell carcinoma (ESCC), a lethal disease, and its underlying molecular mechanisms.
Methods
Differentially expressed genes between ESCC mouse oesophageal cancer tissues and normal tissues were analysed via RNA-seq; among them, SENP5 expression was upregulated, and this gene was selected for further analysis. Immunohistochemistry and western blotting were then used to validate the increased protein level of SENP5 in both mouse and human ESCC samples. The Kaplan‒Meier method and multivariate analysis were used to analyse the relationship between SENP5 expression and ESCC prognosis. Stable SENP5-knockdown (KD) cell lines and conditional knockout (cKO) mice were established to verify the biological function of SENP5. Further RNA-seq comparisons between short hairpin SENP5 (shSENP5)- and short hairpin negative control (shNC)-transfected ESCC cell lines were conducted, and the nuclear factor kappa B (NF-κB)—SLC1A3 axis was identified through bioinformatics analysis. The correlation of SENP5 with signalling pathway components was validated via real-time quantitative PCR (qPCR), western blotting (WB), and immunoprecipitation.
Results
Our study revealed that SENP5 was upregulated in human and mouse ESCC samples, and clinical data analysis revealed a correlation between high SENP5 expression and poor patient prognosis. SENP5 knockdown inhibited tumorigenesis and growth in vivo and suppressed the proliferation, migration, and invasion of ESCC cell lines in vitro. Our study also revealed that SENP5 knockdown enhanced the SUMO1-mediated SUMOylation of NF-kappa-B inhibitor alpha (IκBα), thereby inhibiting the activation of the NF-κB–SLC1A3 axis, which subsequently suppresses ESCC cell energy metabolism and impedes ESCC progression.
Conclusions
Suppression of SENP5 slows the development of ESCC by inhibiting the NF-κB‒SLC1A3 axis through SUMO1-mediated SUMOylation of IκBα. Our research suggests that SENP5 could serve as a prognostic indicator and a target for therapeutic intervention for ESCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, 200032 Shanghai, China.
- Department of Thoracic Surgery, Zhongshan Hospital (Xiamen), Fudan University, 361006 Xiamen, Fujian, China.
- Department of Cardiothoracic Surgery, The Affiliated Jiangyin Hospital of Nantong University, 214400 Jiangyin, Jiangsu, China.
- Department of Vascular Surgery, General Surgery Clinical Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 200025 Shanghai, China.
Förderung
- Training Team for the Leading Expert Team of "Famous Doctors in Jiyang" in Jiangyin City - Tan Lijie Expert Team
- Research project of the Jiangyin Health Commission
- 2021 Clinical Research Navigation Program of Shanghai Medical College of Fudan University
- Outstanding Resident Clinical Postdoctoral Program of Zhongshan Hospital Affiliated with Fudan University
- Xiamen Natural Science Foundation Project in 2022
- Training Team for the Leading Expert Team of “Famous Doctors in Jiyang” in Jiangyin City - Tan Lijie Expert Team
Zitieren
APA
Du, C., Hu, Y., Yang, X., Zhang, Z., Gu, J., Zhang, T., Wang, R., Zhang, S., Tan, L., & Yu, G. (2025). SUMO-Specific Peptidase 5 Promotes Oesophageal Squamous Cell Carcinoma Growth through the NF-κB-SLC1A3 Axis. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl27047
Vancouver
Du C, Hu Y, Yang X, Zhang Z, Gu J, Zhang T, et al. SUMO-Specific Peptidase 5 Promotes Oesophageal Squamous Cell Carcinoma Growth through the NF-κB-SLC1A3 Axis. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl27047
BibTeX
@article{Du2025,
author = {Du, Chaoxiang and Hu, Yunfan and Yang, Xinyu and Zhang, Zhe and Gu, Jianmin and Zhang, Tao and Wang, Renfeng and Zhang, Shaoyuan and Tan, Lijie and Yu, Guiping},
title = {SUMO-Specific Peptidase 5 Promotes Oesophageal Squamous Cell Carcinoma Growth through the NF-κB-SLC1A3 Axis},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl27047}
}
EUVIMED